Comprehensive study of neoadjuvant targeted therapy for resectable non-small cell lung cancer

BACKGROUND: Approximately 30–70% percent of patients with non-small cell lung cancer (NSCLC) still relapse after receiving complete resection and even suffer distant metastasis. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have gradually replaced chemotherapy to become the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Transl Med
Main Authors: Bao, Yi, Gu, Chang, Xie, Huikang, Zhao, Shengnan, Xie, Dong, Chen, Chang, Jiang, Gening, Dai, Chenyang, Zhu, Yuming
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8039639/
https://ncbi.nlm.nih.gov/pubmed/33850890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-21-1134
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados